In District of Columbia v. CVS Corporation, provided written and deposition testimony on market definition, market power, and competitive impact on behalf of a government agency challenging the acquisition of a retail pharmacy chain by a national competitor. Demonstrated the ex-post effect of the acquisition on prices and quality of service. The matter settled before trial.

Advised and provided analytical support to a PBM client proposing a merger in the pharmaceutical benefits management industry. Support included advising strategy for regulatory approval and preparing precise responses to regulatory requests. Analyzed competitive impact to each of multiple customer segments and presented findings to the FTC.